Home / Paracetamol / Canada
CA ATC N02BE01 · updated 2 Nov 2026
Paracetamol shortage in Canada
Is there a Paracetamol shortage in Canada?
Yes. As of 2 Nov 2026, 13 Paracetamol products are reported short in Canada, the first since 20 Jun 2020. The company estimate for the return is 30 Nov 2026 (latest 5 Feb 2027). Main reason: manufacturing problem.
Also short in Italy, Spain, Ireland, Austria, Belgium, Switzerland, Czechia, Norway, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ACÉTAMINOPHÈNE BLASON SHIELD 500 (1000) | LABORATOIRE RIVA INC. | 20 Jun 2020 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP (100mL) | PALADIN LABS INC. | 17 Mar 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEMPRA CHILDREN'S SYRUP (100mL) | PALADIN LABS INC. | 15 May 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP ACETAMINOPHEN BLAZON 500 (1000) | JAMP PHARMA CORPORATION | 31 May 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEMPRA INFANT DROPS (15mL & 24mL) | PALADIN LABS INC. | 3 Aug 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACÉTAMINOPHÈNE COMPRIMÉ TABLET 500 (1000) | LABORATOIRE RIVA INC. | 20 Jun 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PEDIATRIX DROPS (24ml) | TEVA CANADA LIMITED | 3 Jun 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACETAMINOPHEN TABLETS USP 500 MG (100 BTL) | APOTEX INC | 15 Sep 2026 | 5 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACETAMINOPHEN CAPLETS 500 MG (100 BTL) | APOTEX INC | 29 Sep 2026 | 22 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-ACETAMINOPHEN CAPLETS (1000 BTL) | APOTEX INC | 29 Sep 2026 | 11 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH (1000 BTL) | APOTEX INC | 6 Oct 2026 | 4 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NOVO-GESIC (100,1000) | TEVA CANADA LIMITED | 29 Oct 2026 | 30 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NOVO-GESIC FORTE (100,1000) | TEVA CANADA LIMITED | 29 Oct 2026 | 30 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.